VANGUARD CHESTER FUNDS's Vanguard PRIMECAP Fund (VPMCX) has disclosed 171 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2025-03-31. The current portfolio value is calculated to be $70.47 Bil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 1%.
Vanguard PRIMECAP Fund (VPMCX)'s
Total Assets is $71.75 Bil , Total Liabilities is $56.20 Mil , Net Assets is $71.70 Bil.
In Vanguard PRIMECAP Fund (VPMCX)'s current portfolio as of 2025-03-31, the top 5 holdings are
Eli Lilly and Co (LLY), Boston Scientific Corp (BSX), Amgen Inc (AMGN), Microsoft Corp (MSFT) and KLA Corp (KLAC),
not including call and put options.
Vanguard PRIMECAP Fund (VPMCX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for Vanguard PRIMECAP Fund (VPMCX), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for Vanguard PRIMECAP Fund (VPMCX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Vanguard PRIMECAP Fund.